CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ: FMI) today announced the launch of an updated FoundationOne®, incorporating several enhancements that reflect the company’s ongoing commitment to innovation in patient care. The latest version of the most comprehensive genomic profile validated for clinical use features advancements to several components of this unique end-to-end solution, and will be commercially available, replacing the current version of FoundationOne, starting August 4, 2014.
Help employers find you! Check out all the jobs and post your resume.
